MPR

Combination of Asciminib Plus a TKI Offers Hope of Treatment-Free Remission in CML

In the phase 2 FASCINATION trial, researchers sought to improve the rate of major molecular response 4 in patients newly diagnosed with CML.
MPR

Etoposide Can be Safely Eliminated in Pediatric Acute Myeloid Leukemia

Investigators evaluated outcomes for patients with pediatric AML with and without etoposide during first-line induction treatment.
MPR

Novel Low-Sodium Oxybate Formulation Under FDA Review

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for TRN-257, a controlled-release, low-sodium oxybate product, for the treatment of cataplexy or excessive ...
MPR

‘Coming Out’ Linked to Increased Suicide Risk in Sexual Minority Youth

Identity disclosure to a family member or friend linked to increased risks for suicide intention, plan, attempt.
MPR

Epcoritamab Triplet Boosts Outcomes in Relapsed/Refractory Follicular Lymphoma

The EPCORE FL-1 trial evaluated epcoritamb plus lenalidomide and rituximab versus plus lenalidomide and rituximab for efficacy and safety in patients with relapsed/refractory follicular lymphoma in ...
MPR

Timing of Immune Checkpoint Inhibitor Administration Affects Small Cell Lung Cancer Survival

Patients with extensive-stage SCLC who received immunochemotherapy before 15:00 hrs exhibited significantly longer PFS, overall survival.
MPR

Two Deaths Linked to Rabies-Infected Kidney Transplant

HealthDay News — A rare case of rabies linked to an organ transplant has resulted in 2 deaths, federal health officials announced. The US Centers for Disease Control and Prevention (CDC) reported that ...